Omalizumab treatment in brittle asthma
Asthma is a heterogeneous disease with variable characteristics such as lung function, symptoms and control, body weight, pattern of inflammation, and response to treatment. Brittle asthma is one of clinical phenotypes of asthma with unclear pathogenic mechanisms and appropriate treatment. Analysis...
| Main Authors: | , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Termedia Publishing House
2014
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952054/ |